"Our practitioners are highly qualified and the hospitals available throughout the country match the state of the art infrastructure present in western countries."
In Conversation
"We value the alternative medication market at close to USD 1.5 billion, adding USD 700 million for the supplement industry to the 800 million of the…
"Today, Biopas has 500 employees with administrative and operational headquarters, respectively in Panama and Colombia. We are nurturing our business model with complete autonomy, which subsequently…
"Beside the stepping up of our manufacturing efficiency, our improvement efforts have also related to the strengthening of our marketing and sales capacity, which I want…
"Even though Sanofi is positioned as the top pharmaceutical MNC in the country, Indonesia is one of the most challenging markets in the SEA region where…
"Within the Ukrainian healthcare industry BCPP prides itself, above all, on being the first Ukrainian company, in 2003, to have received Good Manufacturing Practices (GMP) certification."
"In my opinion, JKN will certainly drive the growth of the national healthcare sector and life sciences industry in the future."
"Novo Nordisk Austria endeavours to transfer to the people with diabetes our innovative treatments and in the meantime, support affected people with diabetes along their journey…
"I believe having an excellent quality of life is critical to employee attraction and retention."
"Beside very recent initiatives, no significant health reform has been implemented over the 25 years that followed our country’s independence in 1991, and our country’s health…
"Our overall healthcare strategy is to develop an integral solution that enables a treatment continuum between patients and doctors"
"Amaxa relies on a comprehensive portfolio encompassing both in-house developed medicines and in-licensed products, while we also pay the utmost attention to ensure our portfolio is…
